No description available.

[pt] Neste trabalho foi realizada a síntese e caracterização de nanopartículas à base de óxidos de elementos terras raras, para aplicação em terapia fotodinâmica. Nesta, um material fotossensibilizador, ao ser excitado com luz ultravioleta-visível, gera espécies reativas de oxigênio, como oxigênio singleto, um importante agente citotóxico que destrói células cancerígenas. Portanto, nosso principal objetivo é a síntese de nanopartículas cintiladoras, capazes de converter radiação raios X em luz UV-Vis, para posterior funcionalização com o fotossensibilizador azul de metileno, e uso em tratamento de câncer. Assim, nanopartículas de óxido de gadolínio dopado com íons európio e samário foram obtidas através de uma síntese sol-gel. Nanopartículas híbridas de sílica com óxido de gadolínio dopado com íon európio(III) em diferentes concentrações também foram obtidas através de um método denominado de impregnação. Elas foram caracterizadas por diferentes técnicas físico-químicas e de elucidação estrutural, como microscopias eletrônicas de varredura e transmissão, espectroscopia no infravermelho e difração de raios X de pó, comprovando-se a formação das nanopartículas com cristalinidade e propriedades morfológicas adequadas para aplicações no sistemas biológico proposto. Além disso, foram submetidas a análises de fotoluminescência, no qual foi possível obter espectros de excitação e emissão, confirmando a compatibilidade destes materiais com o fotossensibilizador a ser utilizado. Estudos de citotoxidade, para garantir o uso clínico destas nanopartículas, também foram realizados; os resultados mostraram que elas não são consideradas tóxicas em concentrações de 10-500 micrograma.mL(-1) apresentando alta viabilidade celular. Por fim, testes de liberação de espécies reativas de oxigênio estão sendo realizados na ausência e na presença do fotossensibilizador. Com tudo isto, acredita-se que as nanopartículas aqui obtidas tenham grande potencial para uso em terapia fotodinâmica como alternativa para tratamento de câncer. / [en] Herein, rare earth oxides-based nanoparticles were synthesized and characterized for the use in photodynamic therapy. In this approach, a photosensitizer material, when excited with ultraviolet-visible light, generates reactive oxygen species, such singlet oxygen, which is an important cytotoxic agent that destroys cancer cells. Therefore, our main objective is the synthesis of scintillating nanoparticles, capable of converting X-ray radiation into UV-Vis light, designed for further functionalization with the methylene blue photosensitizer and use in cancer treatment. Thus, nanoparticles of gadolinium oxide doped with europium and samarium ions were obtained by sol-gel synthesis. Hybrid nanoparticles of silica with europium(III)-doped gadolinium oxide were also obtained with different doping concentration through the impregnation method. They were characterized with various physicochemical techniques and structural determination involving following instrumentalities: scanning and transmission electronic microscopies, infrared spectroscopy and powder X-ray diffraction, confirming the formation of nanoparticles with crystallinity and morphological properties suitable for applications in the biological system desired. In addition, photoluminescence analyses were conducted, where was possible to record excitation and emission spectra, confirming the compatibility of these materials with the photosensitizer to be used. To ensure the clinical safety of these nanoparticles, cytotoxicity studies were also carried out; results have shown that these materials did not appear to be toxic in concentrations of 10-500 micrograms.mL(-1), presenting high cellular viability. Moreover, the reactive oxygen species generation assays are under investigation in the absence and presence of the photosensitizer. In summary, it is believed that the nanoparticles obtained have a great potential for application in photodynamic therapy as an alternative for cancer treatment.

Anthracene was attached to light activated, ruthenium-based DNA disruptors to probe their distribution in cancer cells. The objective of this research is to understand the photophysical properties (Chapter 2), photoreactivity toward DNA and proteins (Chapter 3), and localization within cancer cells (Chapter 4) of ruthenium complexes that demonstrate promise as photodynamic therapy (PDT) agents. [(AnthbpyMe)(bpy)Ru(dpp)]2+ (1) and [(AnthbpyMe)2Ru(dpp)]2+ (2) absorb visible light with metal-to-ligand charge transfer (MLCT) transitions at 459 nm (16,000 M-1 cm-1 ) and 461 nm (21,000 M-1 cm-1 ), respectively. These species exhibit 3 MLCT emissions at λem = 661 nm and λem = 663 nm for 1 and 2, respectively, while the anthracene show emissions at 450 – 560 nm. The anthracene unit(s) quench the 3 MLCT to give quantum yields (lifetime) of Φem = 0.0059 [398(1) ns] and Φem = 0.0011 [414(1) ns] for 1 and 2, respectively. Voltammetry shows an irreversible anthracene oxidation at 1.23 – 1.28 V, RuIII/II oxidation at 1.53 – 1.55 V, and quasi-reversible reduction couples attributed to dpp0/-1 at 0.98 V. DNA gel shift assays demonstrate that complexes 1 and 2 modify DNA in the presence and absence of 3 O2 upon light activation to convert supercoiled DNA to a mixture of open circular (OC) DNA and a species that exhibit sa distinctly different migration rate than either OC and linear DNA. Binding constants, Kb, for complexes 1 and 2, toward DNA are 3.50 × 105 (3.50 × 104 ) and 4.50 × 103 (4.50 × 102 ) respectively. SDS-PAGE assays show that the complexes 1 and 2 modify bovine serum albumin (BSA) through an 3 O2-dependent mechanism upon light iii activation. The localization and PDT potency of the anthracene-Ru-dpp complexes are tested against F98 cells, which are rat glioma cells that simulate the infiltrative patterns of growth in cancer. Confocal microscopy demonstrates that complexes 1 and 2 internalize and localize primarily along the cell membrane and associate with dot-like vesicles within the cytoplasm. Complexes 1 and 2 show IC50 values of 107 µM and 85 µM, respectively, after 15 min of drug exposure and 1 h of PDT-treatment (λPDT = 455 nm). / Ph. D.

Designing new materials for CO₂ capture and utilization is one of the most challenging research topics. Metal-organic frameworks (MOFs) are one of the most efficient CO₂ adsorbents, as well as an emerging class of heterogeneous catalysts for CO₂ chemical transformations. Highlighted by their high content of active centers, large internal surface areas, tunable pore size, and versatile chemical functionalities, MOFs can serve as highly stable and reusable heterogeneous catalysts and provide a great platform to explore the structure-function relationships for transforming CO₂ into useful chemicals. In this dissertation, we aim to develop a new class of metal-cyclam based robust MOFs as porous materials for CO₂ uptake as well as efficient catalysts for CO₂ chemical transformations, including CO₂ chemical fixation, CO₂ photo- and electroreduction. Chapter 1 introduces the concept and main challenges of CO₂ capture and conversion. The potential of metal-cyclam complexes as molecular catalysts for CO₂ conversion is also mentioned. The current state of the art in designing stable MOFs and azamacrocyclic-based MOFs is briefly discussed. Finally, the strategies, challenges and future outlook of using MOF as catalysts in CO₂ chemical transformation are summarized. Metal-organic frameworks (MOFs) as highly ordered, tunable hybrid materials have shown great promise in photon collection, energy transfer and photocatalytic reactions. In Chapter 2, the fundamental principles of energy transfer in the condensed phase are summarized, and a series of studies in light-harvesting, excited state quenching and photo-excited reactivity occurring within ruthenium-polypyridyl-doped zirconium MOFs are reviewed. The application of MOFs in energy conversion devices such as dye-sensitized solar cells (DSSC) is also discussed. Chapter 3 reports two new robust 3D porous metal-cyclam based Zr-MOFs, VPI-100 (Cu) and VPI-100 (Ni) with potential as heterogeneous catalysts for CO2 chemical fixation. The frameworks are prepared by a modulated synthetic strategy and the structure highlighted by eight-connected Zr₆ clusters and metallocyclams as organic linkers. The VPI-100 MOFs exhibit excellent chemical stability in various organic and aqueous solvents over a wide pH range and show high CO₂ uptake capacity (up to ∼9.83 wt% adsorption at 273 K under 1 atm). Moreover, VPI-100 MOFs demonstrate some of the highest reported catalytic activity values (turnover frequency and conversion efficiency) among Zr-based MOFs for the chemical fixation of CO₂ with epoxides. The MOFs, which bear dual catalytic sites (Zr and Cu/Ni), enable chemistry not possible with the cyclam ligand under the same conditions and can be used as recoverable stable heterogeneous catalysts without losing performance. A follow-up study of CO₂ chemical fixation using Hf analogs of VPI-100 is presented in Chapter 4. Structural characterization and catalytic performance of Hf-VPI-100 are summarized. Moreover, a detailed comparison of VPI-100 and Hf-VPI-100 is made. In situ powder X-ray diffraction (PXRD), quartz crystal microbalance (QCM) and diffuse reflectance infrared Fourier transform spectroscopy (DRIFTs) have been used to probe the interaction between the guest molecules (CO₂/epoxide) and Hf-VPI-100. For CO₂, no specific chemical binding sites in MOFs has been observed and the uptake of CO₂ does not change the crystal structure of Hf-VPI-100. Both QCM and DRIFTs revealed the irreversible binding between the framework and 1,2-epoxybutane. The epoxide uptake per unit cell of VPI-100 MOFs and diffusion coefficients have been calculated by QCM analysis. Transition metal complexes capable of visible light-triggered cytotoxicity are appealing potential candidates for photodynamic therapy (PDT) of cancer. In Chapter 5, two monometallic polyazine complexes, [(Ph₂phen)₂Ru(dpp)]²⁺ and [(Ph₂phen)₂Os(dpp)]⁺ (Ph₂phen = 4,7-diphenyl-1,10-phenanthroline; dpp =2,3-bis(2-pyridyl)pyrazine), were synthesized, characterized and studied as light activated drugs to kill rat malignant glioma F98 cells. Both compounds display strong absorption in visible spectrum, oxygen-mediated DNA and BSA photocleavage and significant photocytotoxicity under blue light irradiation along with negligible activity in the dark. The compounds show approximately five-fold higher cytotoxicity compared the traditional chemotherapeutic drug, cisplatin. Furthermore, [(Ph₂phen)₂Os(dpp)]⁺ shows promising photocytotoxicity in F98 rat malignant glioma cells within the phototherapeutic window with an IC50 value of (86.07±8.48) µM under red light (625 nm) irradiation. In Chapter 6, the mixed-metal supramolecular complex, [(Ph₂phen)₂Ru-(dpp)PtCl₂]²⁺, was found to display significant DNA modification, cell growth inhibition, and toxicity towards F98 malignant glioma cells following visible light irradiation. The design of this complex has a significantly higher potential for membrane permeability than three other FDA-approved anti-cancer agents, including cisplatin, and exhibited a dramatic ten-fold higher uptake by F98 cells than cisplatin in a two-hour window. Based on studies with a rat glioma cell line, the compound has very low cytotoxicity in the dark, but results in substantial cell death upon light treatment. The complex is thus among the first to exhibit all the hallmarks of a very promising new class of PDT agents. / Ph. D. / Increased carbon dioxide (CO₂) emissions have triggered a series of environmental effects, including global warming and ocean acidification. Scientists are trying to develop new materials to capture and convert CO₂ into useful chemical products. However, the main challenge is that CO₂, the gas generated upon burning fossil fuels, has strong C=O bonds that are hard to break. In other words, it is too stable to be easily changed into other compounds. A class of highly porous materials known as metal-organic frameworks (MOFs) possess significant potential for CO₂ adsorption uptake and chemical fixation. MOFs are metal ions or clusters held together by organic linkers to make highly ordered, crystalline 3D structures with tunable porosity and functionality. The design and synthesis of MOFs is similar to playing with Legos at the molecular level; you need to pick the right pieces (metal nodes and linkers) to get your desired structure. In this dissertation, we aim to develop a new class of macrocycle complexes based stable MOFs as porous materials for CO₂ uptake as well as efficient catalysts for CO₂ chemical transformations. We have developed two new stable three dimensional porous frameworks, VPI-100 (Cu) and VPI-100 (Ni) as catalysts for CO₂ chemical fixation. The new 3D robust MOFs named VPI-100 (VPI = Virginia Polytechnic Institute) are assembled by the reaction of zirconium oxo clusters and linkers bearing metal complexes. Using the metal complexes as the linker provides additional metal active sites in the framework that can act as accessible catalytic centers for CO₂ conversion. The VPI-100 MOFs are not only able to convert CO₂ to cyclic carbonates (important industrial chemicals) in high efficiency (~ 98%), but also can be reused for multiple cycles. The heterogeneous catalyst can be easily recovered from the reaction mixture by centrifugation and the active metal centers are earth-abundant transition metals (Cu and Ni), which are cost effective. Additionally, VPI-100 MOFs also show high CO₂ uptake capacity (up to ~10 wt%) at ambient pressure. Since the MOFs can enhance the local concentration of CO₂ around the active catalytic centers located inside the pores of the framework, these materials could be used as catalysts for flow chemistry, which is widely used in industry. We further investigated the CO₂ chemical fixation using Hf analogs of VPI-100. Structural characterization and catalytic performance of Hf-VPI-100 are summarized. Moreover, a detailed comparison of VPI-100 and Hf-VPI-100 is made. Different analytical techniques have been used to further understand the reaction mechanism as well as the interaction between the CO₂/epoxide and the frameworks. These insights would help us to design new MOFs as better catalysts for practical applications.

Photodynamic therapy (PDT) is a multimodality cancer treatment available for the palliation or eradication of systemic and cutaneous malignancies. In this thesis, the application of PDT is for the treatment of non-melanoma skin cancer (NMSC). While PDT has a well-documented track record, there are, at this time no significant indicators to suggest the superiority of one treatment regime over the next. The motivation for this work is to provide additional evidence pertaining to PDT treatment variables, and to assist in optimising PDT treatment regimes. One such variable is the treatment light dose. Determining the light dose more accurately would assist in optimising treatment schedules. Furthermore, choice of photosensitiser pro-drug type and application times still lack an evidence base. To address issues concerning treatment parameters, fluorescence spectroscopy – a valuable optical diagnostic technique – was used. Monitoring the in vivo PpIX fluorescence and photobleaching during PDT was employed to provide information pertaining to the progression of treatment. This was demonstrated by performing a clinical study at the Photobiology Unit, Ninewells Hospital and Medical School, Dundee. Two different photosensitiser pro-drugs – either 5-aminolaevulinic acid (ALA) or its methyl ester (MAL) – were investigated and based on the fluorescence and pain data recorded both may be equally suitable for topical PDT. During PDT, surface fluorescence is observed to diminish with time – due to photobleaching – although cancerous cells may continue to be destroyed deep down in the tissue. Therefore, it is difficult to ascertain what is happening at depth in the tumour. This raised the questions; How long after surface PpIX fluorescence has diminished is the PDT treatment still effective and to what depths below the surface is effective treatment provided? In order to address these important questions, a three-dimensional (3D) Monte Carlo radiation transfer (MCRT) model was used to compute the light dose and the ¹O₂ production within a tumour, and the PpIX fluorescence emission from the tumour. An implicit dosimetry approach based on a single parameter – fluorescence photobleaching – was used in order to determine the ¹O₂ generation, which is assumed to be related to tissue damage. Findings from our model recommended administering a larger treatment light dose, advocating an increase in the treatment time after surface PpIX fluorescence has diminished. This increase may ultimately assist in optimising PDT treatment regimes, particularly at depth within tumours.

L'avancée technologique dans les nanosciences a permis le développement d'une large gamme de matériaux nanostructurés aux applications biomédicales. Ces outils, constitués de matériaux différents, ont été développés à des fins de diagnostic et de thérapie pour réaliser notamment le ciblage, le marquage cellulaire, l'imagerie médicale et pour concevoir des systèmes de délivrance de médicaments pour le traitement de cancers ou de maladies infectieuses. La création de nano-objets regroupant l'ensemble de ces propriétés de type théranostique constitue une étape essentielle vers un traitement personnalisé et non invasif des cancers solides de petite taille. Dans cette thèse, une première partie est consacrée à la mise au point et à l'utilisation de nanoparticules de silice mésoporeuse pour le traitement des rétinoblastomes. Ce travail visait à améliorer la thérapie photodynamique en augmentant la biodisponibilité de molécules actives dans les cellules cancéreuses par deux stratégies : leur vectorisation par un nano-objet et le ciblage spécifique des cellules cancéreuses. Pour cela, les profils d'expression des récepteurs du mannose ont été analysés et les récepteurs MRC2 et CD209 se sont révélés être de bons candidats pour une thérapie ciblée du rétinoblastome. La deuxième partie des recherches réalisées s'oriente vers l'élaboration de différents nanosystèmes pour le traitement des cancers et l'imagerie médicale. Premièrement, des nanotransporteurs de principe actif à relargage pH-sensible, structurés à partir de nanoparticule de silice mésoporeuse, ont été étudiés. Ces systèmes de délivrance, sous l'effet de stimuli internes, se sont révélés être très efficaces in vitro et ex vivo pour le traitement du cancer du côlon. Deuxièmement, le potentiel de délivrance contrôlée de molécules anticancéreuses renfermées dans des nanomachines soumises à une activation externe biphotonique, a été démontré sur des cellules de cancer du sein. Enfin, les propriétés de nanoparticules magnétiques de polymères de coordination cyano-pontés se sont révélées très prometteuses pour une utilisation en tant que nouvel agent de contraste intravasculaire pour l'imagerie par résonance magnétique in vivo. / The technological advance in nanoscience has allowed the development of a wide range of nanostructured materials for biomedical applications. These tools, composed of different materials, have been developed for diagnosis and therapy, in particular to achieve targeting, cellular labeling, medical imaging and to design drug delivery systems for the treatment of cancer or infectious diseases. The elaboration of nano-tools possessing these theranostic properties would be a major step towards personalized and non-invasive treatments of small solid cancers.In this thesis, the first part is devoted to the development and the application of mesoporous silica nanoparticles for the treatment of retinoblastoma. The aim of this work was to improve photodynamic therapy by increasing the bioavailability of active molecules in cancer cells following two strategies: their vectorization through nanodevice and the specific targeting of cancer cells. For this, expression profiles of mannose receptors were analyzed and both MRC2 and CD209 receptors were found to be interesting candidates for targeted therapy of retinoblastoma.The second part corresponds to a multidisciplinary approach focused on the research of different nanosystems designed for cancer treatment and medical imaging. We first studied pH-operated hybrid silica nanocarriers designed for drug release. Under internal stimuli, these delivery systems have shown to be very efficient in vitro and ex vivo against colon cancer. Then, we demonstrated the potential of nanoimpellers designed for anticancer drug delivery mediated by external two-photon activation on breast cancer cells. Finally, we report the promising use in vivo of new magnetic cyano-bridged coordination polymer nanoparticles as an efficient intravascular magnetic resonance imaging contrast agent.

Les molécules chirales représentent environ 60% des médicaments présents sur le marché pharmaceutique et plus de 80% des médicaments en développement avec plus de 150 milliards de dollars de chiffre d’affaire pour l’année 2002. Les intermédiaires chiraux sont fortement demandés dans l’industrie pharmaceutique atteignant 15 milliards de dollars de chiffre d’affaire en 2009. D’autres domaines en sont demandeurs avec une répartition d’environ 15% dans l’agrochimie et 5% pour la parfumerie. L’obtention de composés d’intérêt pharmaceutique de façon asymétrique est un réel défi et une réelle nécessité. Ces molécules possèdent une architecture spatiale qui entraîne des interactions spécifiques et des affinités particulières avec les enzymes ou des récepteurs biologiques chiraux. L’utilisation de catalyseurs pour accéder à des composés organiques chiraux et plus précisément l’oxydation d’alcanes prochiraux ou d’oléfines constitue un domaine en essor ces dernières décennies. Pour parvenir à synthétiser des molécules chirales, l’industrie pharmaceutique s’est tournée vers l’utilisation de biocatalyseurs en partie pour réaliser différentes réactions stéréo-contrôlées avec la nécessité de séparer les mélanges racémiques par résolution enzymatique. Cependant, les biocatalyseurs présentent un inconvénient majeur qui est généralement le faible rendement en composé chiral recherché et nécessite un savoir faire pour la manipulation de ces enzymes. Les métalloporphyrines sont des catalyseurs comportant un macrocycle tétrapyrrolique et différentes fonctionnalisations en positions méso. Ces molécules ont fait l’objet de nombreuses études qui ont conduit à la synthèse de métalloporphyrines chirales très complexes. Malheureusement, leur synthèse est souvent longue avec de faibles rendements et leur application à un nombre limité de substrats ne permet pas leur généralisation. Ce travail de thèse, développé pour la première fois au laboratoire, s’inscrit dans le cadre d'un contrat CIFRE, dans le but de parvenir à la synthèse de porphyrines chirales facilement accessibles, applicables dans des réactions d’oxydation énantiosélectives efficacement (stabilité). Le premier objectif visé est la synthèse de porphyrines chirales dont la structure ciblée comporte des groupements hétérocycliques azotés chiraux en position méso, reliés par une liaison carbone-hétéroatome (C-N). Nous avons pu atteindre 4 séries de porphyrines qui ont été évaluées dans des réactions d’oxydation énantiosélectives (époxydation, hydroxylation). Le deuxième objectif visé est d’exploiter les propriétés électroniques particulières des porphyrines permettant l’application des porphyrines en tant que photosensibilisant après photoactivation en thérapie anticancéreuse. L’étude des paramètres physiques est primordiale pour déterminer la longueur d’onde d’activation et le rendement quantique. Nous avons souhaité utiliser nos porphyrines et leurs précurseurs en tant qu’agents antiparasitaires, sans photoactivation dans un premier temps, conduisant à la découverte d’activités très intéressantes sur certaines espèce de leishmanies. Enfin, leur application sur P. falciparum nous a permis d’isoler une molécule avec une activité très intéressante. Dans les deux cas, des manipulations avec photoactivation sont en cours. / Chiral molecules represent about 60% of drugs in pharmaceutical market and over 80% of drugs in development with more than 150 billion dollars in 2002. Chiral intermediates are in high demand in the pharmaceutical industry producing a turnover of 15 billion dollars in 2009. Other areas are seekers of chiral molecules with a distribution of about 15% in agrochemicals and 5% for the perfume. Asymmetrically production of compounds of pharmaceutical interest is a real challenge. These molecules have a spatial architecture that results in specific interactions and affinity with the enzymes or biological chiral receptors. The use of catalysts to synthesis chiral organic compounds, and more specifically to oxidize alkenes and alkanes having prochiral positions, is a very important area extensively studied in recent decades with few positive results. To achieve the synthesis of chiral molecules, the pharmaceutical industry has turned to the use of biocatalysts, in part, to perform various stereo-controlled reactions with systematically followed by separation of the different isomers by different methodes. However, biocatalysts have a major disadvantage relative to low yields of chiral compound and requires expertise for handling these enzymes. Metalloporphyrins are tetrapyrrolic macrocyle substituted in meso position with various functional groups and incorporating metals (Fe, Mn, Co, Ru). These molecules have been extensively studied and led to the synthesis of many complex chiral metalloporphyrins. Unfortunately, their synthesis is often long with low yields and their application to a limited number of substrates is a major drawback. The first objective of this work is the synthesis of original chiral porphyrins. The targeted structure contains chiral heterocyclic nitrogen groups in two meso positions, connected by a carbon-heteoatom bond (C-N). We were able to reach 4 porphyrins-series that have been evaluated as catalyst in oxidation reactions (epoxidation, hydroxylation). The second objective is to take advantage of specific electronic properties of porphyrins for applications as photosensitizer after photoactivation for cancer by photodynamic therapy. The use of this therapy increased during last decades but poor specificity and solubility of the different porphyrins used in clinic against many cancers prompt us to investigate this area. The study of the physical parameters is essential to determine wavelength activation and quantum yield of a photosensitizer. We wanted to use our porphyrins and their precursors as antiparasitic agents, with and without photoactivation against L. donovani, L. major, T. brucei brucei. Malaria is caused by a protist of the genus of Plasmodium. This parasite has an iron deficiency on one hand and cannot biosynthesize certain amino acids. Strucure analogy of porphyrins with heme led us to evaluate antimalarial activity of several porphyrins against P. falciparum.

A Terapia Fotodinâmica (TFD) é um tratamento usado principalmente na terapia anticâncer e que depende da retenção de um composto fotossensibilizante nas células tumorais e posterior irradiação dessas células com luz visível. Após ativação, o fármaco pode gerar espécies reativas de oxigênio (EROs), como o oxigênio singlete (1O2) e radicais (O2-, OH), que são capazes de danificar membranas, DNA e outras estruturas celulares, induzindo a apoptose ou necrose das células tumorais. O ácido fólico, por ser super expressado na superfície das células de alguns tipos de cânceres (principalmente os ginecológicos), pode desempenhar o papel de vetorizador, tornando-se um importante aliado aos sistemas de liberação de fármacos. Neste trabalho foi avaliado o uso de ácido fólico como aditivo aos lipossomas contendo ftalocianina de cloro-alumínio como fármaco fotossensibilizante, aplicados em TFD com células MCF7. Os estudos demonstraram que os sistemas lipossomais desenvolvidos apresentam tamanho nanométrico (menor que 200 nm) e possuem biocompatibilidade quando avaliados em cultura celular de monocamada. Além disso, foi possível observar o efeito fototóxico satisfatório das formulações e o aumento da internalização do fármaco, quando utilizado o ácido fólico como vetorizador. / Photodynamic Therapy (PDT) is mainly used in anticancer therapy. The efficiency of this treatment is dependent on retention of photosensitizer compound at the tumor cells and posterior irradiation of these cells with visible light. After activation, the drug may generate reactive oxygen species (ROS) such as singlet oxygen (1O2) and radicals (O2-, OH), which are capable of damaging membranes, DNA and other cell structures, inducing apoptosis or necrosis of tumor cells. Folic acid is super-expressed on the surface of some cancers cells (especially gynecological cancer cells) and can play the role of target system, becoming an important ally for drug delivery systems. This study evaluated the use of folic acid as an additive to liposomes containing chloro-aluminum phthalocyanine as a photosensitizer drug, applied in PDT with MCF7 cells. These studies showed that liposomal systems have nanometer size (less than 200 nm) and have biocompatibility when evaluated in monolayer cell culture. Moreover, it was possible to observe satisfactory phototoxic effect of the formulations and increased internalization of the drug when folic acid is used.

A reabsorção óssea alveolar associada as perdas dentais constitui uma condição inerente ao processo de cicatrização fisiológico natural. Técnicas como a instalação de implantes imediatos e técnicas de preservação alveolar têm sido sugeridas com o objetivo de limitar as alterações adversas sofridas pelo processo alveolar. Contudo, frequentemente as perdas dentárias estão associadas a infecções crônicas que tradicionalmente contraindicariam os procedimentos de enxerto ou implantes imediatos, a menos que meticulosos debridamento e irrigação alveolar associados a adequado protocolo antibiótico pré e pós-operatório sejam empregados. Alternativas precisam ser testadas para a substituição do uso indiscriminado de antibioticoterapia sistêmica. O objetivo do presente estudo foi avaliar o efeito da TFDa na descontaminação de alvéolos infectados previamente a instalação de implantes imediatos e na cicatrização de alvéolos pós-extração associados ou não ao uso de enxertos xenógeno através de análises microtomográficas e histomorfométricas. Para tanto, foram selecionados 8 cães, os quais foram submetidos a uma fase de indução de doença periodontal por ligadura, seguida por um período de estabelecimento da doença. Após a exodontia dos prémolares bilaterais, aleatoriamente os alvéolos de um lado da mandíbula foram descontaminados por debridamento mecânico associado a irrigação com solução salina (grupo controle) e do outro lado por debridamento mecânico e irrigação com solução salina associados a terapia fotodinâmica antimicrobiana (grupo teste), e subsequentemente submetidos a instalação de implantes imediatos, dando origem aos grupos GT-I (Grupo Teste - Implante) e GC-I (Grupo Controle - Implante). Os demais alvéolos, foram utilizados para o estudo da dinâmica de cicatrização alveolar. Os sítios foram aleatoriamente alocados em: GT-C (Grupo teste - Coágulo), GT-BO (Grupo Teste - Bio-Oss®), GT-BOC (Grupo Teste - Bio-Oss® Collagen), GC-C (Grupo Controle - Coágulo), GC-BO (Grupo Controle - Bio-Oss®) e GC-BOC (Grupo Controle - Bio-Oss® Collagen). Após 12 semanas, os cães foram sacrificados e as amostras processadas para as análises de microtomografia computadorizada, histologia e histomorfometria. Na avaliação da cicatrização dos alvéolos pós-extração, embora os alvéolos descontaminados com TFDa (GT-C, GT-BO, GT-BOC) tenham apresentado melhores resultados numéricos, em relação a altura da crista óssea vestibular (ACOV) e a dimensão buco-lingual (DBL), não foram evidenciadas diferenças relevantes na análise histomorfométrica. Apenas a ACOV, mensurada na avaliação microtomográfica bidimensional, demonstrou-se significativamente inferior nos alvéolos do grupo teste que não receberam material de enxerto (GT-C) quando comparados aos respectivos alvéolos do grupo controle (GC-C). Na avaliação dos implantes imediatos, a análise histomorfométrica dos parâmetros: reabsorção da crista óssea vestibular (RCOV) e contato osso implante (BIC) demonstrou resultados significantemente superiores no GT-I em relação ao GC-I, e do parâmetro densidade óssea (DO) demonstrou apenas resultado numericamente superior no GT-I em relação ao GC-I. Todas as análises microtomográficas bidimensionais (RCOV) e tridimensionais (volume ósseo BV, porcentagem óssea BV/TV, densidade de superfície óssea BS/TV, espessura trabecular Tb.TH, número de trabéculas Tb.N e separação trabecular Tb.SP) demonstraram resultados significantemente melhores nos implantes do grupo teste (GT-I) em relação aos implantes do grupo controle (GC-I). A TFDa demonstrou potencial como agente de descontaminação de alvéolos pósextração periodontalmente infectados, previamente a instalação de implantes imediatos e na cicatrização de alvéolos pós-extração associados ou não a materiais de enxerto xenógenos, sem o uso de antibioticoterapia sistêmica associada. / Alveolar bone resorption following tooth loss is an inherent condition of the natural healing process. Therefore, several techniques, such as immediate implants placement and post extraction socket preservation, have been suggested in order to limit the adverse changes suffered by the alveolar process. However, extraction sockets commonly results from the removal of teeth affected by chronic infection, which conventionally contraindicates immediate bone graft and implant placement unless meticulous wound debridement and alveolar irrigation associated to a suitable pre- and post-operatory antibiotic protocol are employed. Alternatives ought to be tested in order to substitute the indiscriminate use of systemic antibiotic therapy. The aim of the present study was to evaluate the effect of the antimicrobial photodynamic therapy (aPDT) in the decontamination of infected post extraction sockets, previously to immediate implant placement and in the healing of post extraction sockets associated or not to xenografts. In the first phase, periodontitis was induced with ligatures in the mandibular premolars of eight beagle dogs. After 2 months, in the second phase of the study the dogs had their mandibular bicuspids bilaterally extracted, and randomly one hemi-mandible was decontaminated by mechanic debridement associated to saline solution irrigation (Control Group - CG), and the other hemi-mandible was decontaminated with mechanic debridement and saline solution irrigation associated to antimicrobial photodynamic therapy (Test Group - TG). Thereafter, 3 immediate implants in each side of the mandible were placed and the following groups were devised: TG-I (Test Group - Implant) and CG-I (Control Group - Implant). The remaining sockets were used for the study of the healing dynamic. The sockets were randomly assigned to the following groups: Test Group - Blood clot (TG-BC), Test Group Bio- Oss® (TG-BO), TG - BOC (Test Group Bio-Oss® Collagen), Control Group - Blood Clot (CG-BC), Control Group - Bio-Oss® (CG-BO) and Control Group - Bio-Oss® Collagen (CG-BOC). After 12 weeks, the dogs were sacrificed and the specimens were processed for microtomographic, histological and histomorphometric analysis. When the post extraction healing process was evaluated, the aPDT decontaminated sockets (TG-BC, TG-BO and TG-BOC) presented better numerical results in comparison to both buccal bone crest height (BCL) and in the bucco-lingual dimension (BLD). However, there were no statistically differences among the groups for these parameters in the histomorphometric analysis. Only the BCL measured in the two-dimensional microtomographic analysis showed statistic better results in the TG-BC when compared to the CG-BC. In the evaluation of the immediate implant placement the histomorphometric analysis presented statistically better results for the TG-I in the bone-implant contact (BIC), as well as in the vertical buccal bone loss (VBBL). The bone density (BD) was numerically better in the TG-I than in the CG-I. Both two-dimensional (VBBL) and three-dimensional (bone volume BV, percentage of the total bone volume - BV/TV, bone surface density - BS/TV, trabecular thickness Tb.Th, trabecular separation Tb.Sp and trabecular number TB.N) microtomographic analysis showed statistically better results in the TG-I. The aPDT showed potential in the decontamination of infected post extraction sockets previously to immediate implant placement and in the healing of post extraction sockets associated or not to xenogeneic grafts, without the use of systemic antibiotics.

A terapia foto-dinâmica consiste na irradiação luminosa de um determinado tecido ou microorganismo previamente exposto à ação de um corante foto-sensibilizador. Ela é eficazmente utilizada em neoplasias e em processos infecciosos. No entanto, poucos estudos avaliam o efeito desta terapia em reparação tecidual. Estes trabalhos mostram resultados que variam entre satisfatórios e não-satisfatórios. Além disso, os estudos que envolvem a terapia com laser em baixa intensidade e a terapia foto-dinâmica em reparação tecidual preocupam-se, na maioria das vezes, com a organização e quantificação dos componentes da matriz extra-celular. Estudar o epitélio, em contrapartida, por meio das proteínas expressas pelos queratinócitos é igualmente importante, sabendo-se que a reparação da ferida depende também da organização e proliferação das células epiteliais. Este trabalho avaliou a reparação tecidual de excisões realizadas em dorso de ratos submetidas à irradiação com laser em baixa intensidade ou terapia foto-dinâmica mediada pelo corante azul de metileno. Para tal, realizou-se a análise morfológica e histomorfológica das feridas em determinados tempos experimentais, além da análise imunoistoquímica das citoqueratinas 10 e 14 e p63. Os resultados mostraram que a reparação tecidual foi favorecida com a irradiação laser em baixa intensidade, o que foi confirmado através das análises morfológica e histo-morfológica que mostraram fechamento prévio da ferida para este grupo experimental. Além disso, a expressão de citoqueratina 10 na língua epitelial formada nas feridas pertencentes ao grupo Laser precedeu a expressão da mesma nos outros grupos, o que indicou uma maturação acelerada do epitélio para este grupo. O grupo da terapia foto-dinâmica não apresentou aceleração da reparação tecidual bem como não a prejudicou. Isto sugere que a reparação tecidual frente à irradiação laser é diferente daquela encontrada com a terapia foto-dinâmica. Além disso, não houve atraso da reparação tecidual com a terapia foto-dinâmica, sugerindo que esta terapia foi segura e que devem ser consideradas suas vantagens em situações de infecção. / The photodynamic therapy involves delivering visible light of the appropriate wavelength into a tissue or microorganism previously exposed to a photo-sensitive dye. Its use is widely spread between neoplastic and infeccious diseases. Nevertheless, its effects upon wound healing has not yet been completely verified and the few studies concerning this subject present whether good or bad results. In addition, studies that involve low intensity laser therapy or photodynamic therapy on wound healing concern mostly on the organization and quantification of the extracellular matrix components. Studying the epithelium, on the other hand, by the keratinocyte expressed proteins is equally important, once the wound healing depends also of the organization and proliferation of the epithelial cells. This study evaluated the wound healing of excisions performed on the back of rats submitted to low intensity laser therapy or photodynamic therapy mediated by methylene blue dye. Morphological and histo-morphological analysis of the wounds in pre-determined periods were performed, as well as immunohistochemistry of citokeratins 10 and 14 and p63. The results showed that the wound healing was enhanced by the low intensity laser therapy, which was confirmed by the morphological and histomorphological analysis. The wound closure was previously seen for the laser group. The citokeratin 10 expression on the epithelial tongue of the wounds that belong to the laser group preceded the expression in the other groups, which indicated an accelerated maturation of this epithelium. The photodynamic therapy group did not present accelerated wound healing but did not present any delay as well. This suggests that the wound healing found for the laser group differs from that found for the photodynamic therapy group. Moreover, the lack of delay presented by the photodynamic therapy suggests a safe therapy with advantages regarding disinfection that should be considered in specific situations.